The Definitive Peptide Research Reference Guide — Compound Review

Severity: Mild

Ipamorelin Side Effects

Ipamorelin is considered one of the most selective GHRPs with a favorable side effect profile. It does not significantly stimulate cortisol or prolactin release at typical research doses.

Medical Disclaimer: This page is for informational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before using any research chemical or peptide. Ipamorelin is not FDA-approved for human use (unless noted).

Common Side Effects

Injection Site Reactions

Mild redness or discomfort at the injection site, the most commonly reported local reaction.

Headache

Mild headaches reported, particularly early in use, possibly related to GH-induced changes in intracranial pressure.

Water Retention

Mild fluid retention possible due to GH-related effects, typically less pronounced than with other GHRPs.

Flushing

Brief facial flushing immediately following injection reported by some users.

Rare or Serious Side Effects

Nausea

Mild nausea reported in a small subset of users, typically at higher doses.

Increased Hunger

Ipamorelin acts on ghrelin receptors; some users report increased appetite, though this is less pronounced than with other GHRPs like GHRP-6.

Contraindications

Ipamorelin should not be used in the following situations:

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Hypersensitivity to any component

Frequently Asked Questions

Does ipamorelin increase cortisol?

Unlike GHRP-2 and GHRP-6, ipamorelin does not significantly stimulate cortisol or ACTH release at typical research doses. This is considered one of its key advantages.

Does ipamorelin cause hunger?

Ipamorelin has minimal effect on hunger compared to other GHRPs like GHRP-6, which significantly stimulates appetite. Some users report mild increased hunger.

Is ipamorelin safer than GHRP-6?

Ipamorelin is generally considered more selective and better-tolerated than GHRP-6, with less cortisol stimulation and less appetite stimulation.

Can ipamorelin cause gynecomastia?

Ipamorelin does not significantly stimulate prolactin at typical research doses, making it less likely to cause gynecomastia compared to some other peptides.

What happens if I take too much ipamorelin?

Higher doses may increase the risk of water retention, headache, and nausea. Desensitization of GH receptors may also occur with excessive dosing.

Source Research-Grade Ipamorelin

Purgo Labs provides HPLC-verified, third-party tested Ipamorelin for legitimate research purposes. Every batch includes a certificate of analysis.

Shop Ipamorelin at Purgo Labs

Related Research Guides

Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.